Skip to content

The effect of oral product containing amla fruit on women’s androgenic alopecia

Evaluation of the effect of oral product containing Amla fruit (Phyllanthus emblica L.) on women’s androgenic alopecia: a Randomized Controlled Clinical Trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201010048979N2
Enrollment
60
Registered
2021-10-27
Start date
2021-10-16
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group: Each eligible patient will take 30 cc of medication (10 cc of amla syrup after each meal) daily for 12 weeks. Intervention 2: Control group: Each eligible patient w

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women aged 18 to 60 years old Type 1 to 2 hair loss according to the Hamilton Hair Loss Criterion that has lasted more than 6 months Patient consent approval to participate in the study

Exclusion criteria

Exclusion criteria: Records of using any typical products to prevent hair loss or stimulate hair growth in the past 2 months Utilizing 5 a reductase inhibitors in the past 2 months Records of taking anti-androgenic drugs in the past 2 months Records of systemically taken steroids for more than 14 days in the past 2 months Any active diseases in the head including scalp infection in the past 6 months Records of any types of cancer or autoimmune diseases Any records of hair transplantation Pregnancy and lactation The history of underlying diseases of diabetes, hypothyroidism, polycystic ovary syndrome The history of acute illness in the last 2 months

Design outcomes

Primary

MeasureTime frame
Number of hair strands. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Terminal hair to Volos hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Ratio of anagen to telogen hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Physician satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.;Patient satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Akhbari

Tehran University of Medical Sciences

mentalhealth8981@gmail.com+98 21 8899 3656

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026